The phrase "a generic copy" is correct and usable in written English.
It can be used to refer to a standard or non-specific version of a document, item, or product that lacks unique features or characteristics.
Example: "The report provided was just a generic copy of the previous year's findings, lacking any new insights."
Alternatives: "a standard version" or "a typical duplicate".
(In the United States, the introduction of a generic copy is almost automatic once a brand's patent expires, and multiple generics often flood the market, analysts say).
Generic drug developers need samples of brand-name drugs to show that a generic copy is equivalent to the original.
BARR LABORATORIES, Pomona, N.Y., a leading maker of birth-control pills, said it had begun selling a generic copy of Johnson & Johnson's Ortho Tri-Cyclen oral contraceptive.
WASHINGTON — Just about anyone who has gone to a pharmacy and paid for a prescription knows that a generic copy costs much less than the brand-name drug.
They can get what is called a compulsory license -- in effect, they seize a patent -- and manufacture or import a generic copy of a drug, paying the patentholder a reasonable royalty.
Finally Vectura added 16.25p to 137.25p after it announced its partner Sandoz had received Danish approval for the sale of an inhaled lung drug, AirFluSal Forspiro, that analysts say could be a generic copy of GlaxoSmithKline's blockbuster drug Advair.
German drug maker Bayer has said it will challenge India's decision to allow the production of a cheaper generic copy of a patented cancer drug.
The United States Court of Appeals for the Federal Circuit in Washington upheld a lower court's finding that a planned generic copy by Ranbaxy Laboratories would infringe a patent protecting Lipitor through March 2010.
If there is real human need Trips allows the country to manufacture a cheap (generic) copy of the drug.
This footnote was appended on 5 October 2015: The article says that campaigners want the patent of Kadcyla, a breast cancer drug, effectively torn up to "allow the import or manufacture of a cheap generic copy".
The health secretary, Jeremy Hunt, has been challenged by a coalition of cancer patients, clinicians and campaigners to effectively tear up the patent on a breast cancer drug that has been dropped from the NHS because of its cost and allow the import or manufacture of a cheap generic copy [see footnote].
